A Zika virus drug being developed by BioCryst Pharmaceuticals is yielding promising results, new research revealed. Scientists tested the drug in a preclinical mice study.
(Photo : Agência Brasília | Flickr)
There is still no specific treatment or vaccine for the Zika virus infection, but a new drug being developed by North Carolina-based company BioCryst Pharmaceuticals, Inc. is yielding promising results.
In a new preclinical study, a dose of the company’s antiviral drug BCX4430 improved…
BioCryst Zika Virus Drug Shows Promise In Mice Study
No comments:
Post a Comment